The dual role of LRP1 in both subtypes, as highlighted by Sun et al. [54] and Petschner et al. [48], underscores its potential as a pleiotropic target for migraine therapy, particularly given its involvement in oxidative stress (MO) and retinoic acid metabolism (MA-MO overlap). Here, LRP1 is linked to migraine disorder.